These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 6719390

  • 1. Plasma contact activation and decrease of factor V activity on negatively-charged polyelectrolytes.
    Boffa MC, Dreyer B, Pusineri C.
    Thromb Haemost; 1984 Feb 28; 51(1):61-4. PubMed ID: 6719390
    [Abstract] [Full Text] [Related]

  • 2. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF, Silver LD, Schapira M, Colman RW.
    J Clin Invest; 1984 Apr 28; 73(4):954-62. PubMed ID: 6561202
    [Abstract] [Full Text] [Related]

  • 3. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T, Dubin A, Moore W, Tanaka R, Travis J.
    Lab Invest; 1996 May 28; 74(5):861-70. PubMed ID: 8642782
    [Abstract] [Full Text] [Related]

  • 4. Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions.
    Brunnée T, Reddigari SR, Shibayama Y, Kaplan AP, Silverberg M.
    Clin Exp Allergy; 1997 Jun 28; 27(6):653-63. PubMed ID: 9208186
    [Abstract] [Full Text] [Related]

  • 5. Studies on contact activation: effects of surface and inhibitors.
    Cameron CL, Fisslthaler B, Sherman A, Reddigari S, Silverberg M.
    Med Prog Technol; 1989 Jun 28; 15(1-2):53-62. PubMed ID: 2530427
    [Abstract] [Full Text] [Related]

  • 6. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F, Ratnoff OD.
    J Lab Clin Med; 1983 Oct 28; 102(4):487-99. PubMed ID: 6604770
    [Abstract] [Full Text] [Related]

  • 7. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA.
    Thromb Haemost; 1999 Sep 28; 82(3):1033-40. PubMed ID: 10494760
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting the rate of contact activation in human plasma.
    Brunnée T, Coy G, Reddigari SR, Silverberg M.
    Agents Actions Suppl; 1992 Sep 28; 38 ( Pt 2)():231-6. PubMed ID: 1462830
    [Abstract] [Full Text] [Related]

  • 9. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
    Shimada T, Kato H, Maeda H, Iwanaga S.
    J Biochem; 1985 Jun 28; 97(6):1637-44. PubMed ID: 3928613
    [Abstract] [Full Text] [Related]

  • 10. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.
    Shibayama Y, Joseph K, Nakazawa Y, Ghebreihiwet B, Peerschke EI, Kaplan AP.
    Clin Immunol; 1999 Jan 28; 90(1):89-99. PubMed ID: 9884356
    [Abstract] [Full Text] [Related]

  • 11. Functional characterization of a variant prekallikrein (PK Zürich).
    Wuillemin WA, Furlan M, von Felten A, Lämmle B.
    Thromb Haemost; 1993 Sep 01; 70(3):427-32. PubMed ID: 8259543
    [Abstract] [Full Text] [Related]

  • 12. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP.
    Thromb Haemost; 2001 Jan 01; 85(1):119-24. PubMed ID: 11204562
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H, Orito Y, Jingushi N, Iwanaga S, Morita A, Chinzei Y, Yuda M.
    FEBS J; 2007 Aug 01; 274(16):4271-86. PubMed ID: 17645545
    [Abstract] [Full Text] [Related]

  • 14. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.
    Goldsmith GH.
    J Lab Clin Med; 1980 Aug 01; 96(2):222-31. PubMed ID: 7400661
    [Abstract] [Full Text] [Related]

  • 15. Contact activation: a revision.
    Schmaier AH.
    Thromb Haemost; 1997 Jul 01; 78(1):101-7. PubMed ID: 9198136
    [Abstract] [Full Text] [Related]

  • 16. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS, Gallin JI, Kaplan AP.
    J Clin Invest; 1974 Feb 01; 53(2):622-33. PubMed ID: 11344577
    [Abstract] [Full Text] [Related]

  • 17. Plasma contact activation: a revised hypothesis.
    Schmaier AH.
    Biol Res; 1998 Feb 01; 31(3):251-62. PubMed ID: 9830513
    [Abstract] [Full Text] [Related]

  • 18. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J, Huyke R, Vogel G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Feb 01; 111(4):492-6. PubMed ID: 6083916
    [Abstract] [Full Text] [Related]

  • 19. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I.
    Blood Coagul Fibrinolysis; 1993 Oct 01; 4(5):671-8. PubMed ID: 7507361
    [Abstract] [Full Text] [Related]

  • 20. Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin.
    Cornelius RM, Sanchez J, Olsson P, Brash JL.
    J Biomed Mater Res A; 2003 Nov 01; 67(2):475-83. PubMed ID: 14566788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.